Pigs - phosphatidylinositol glycan anchor biosynthesis, class S Gene
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 303277
Summary
Predicted to be involved in attachment of GPI anchor to protein. Predicted to be part of GPI-anchor transamidase complex. Human ortholog(s) of this gene implicated in developmental and epileptic encephalopathy. Orthologous to human PIGS (phosphatidylinositol glycan anchor biosynthesis class S). [provided by Alliance of Genome Resources, Apr 2022]
Pigs Products (2)
| mRNA | Protein | Name |
|---|---|---|
| NM_001006602.1 | NP_001006602.1 | GPI transamidase component PIG-S |
| NM_001006602.1 | NP_001006602.1 | GPI transamidase component PIG-S |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
GPI transamidase component PIG-S |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(40)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-17498 | Atenolol | Antagonist | 98.85% | Yes |
| HY-14648A | Dexamethasone acetate | Agonist | 99.86% | Unkown |
| HY-121383 | Labetalol | Antagonist | 99.94% | Unkown |
| HY-B1770 | Sodium Iodide,99% | 99.6% | Unkown | |
| HY-17403 | Manidipine dihydrochloride | Inhibitor | 99.84% | Unkown |
| HY-B0519A | Tylosin | Inhibitor | 98.0% | Unkown |
| HY-70050C | Alosetron Hydrochloride | Antagonist | 99.63% | Unkown |
| HY-B0693 | Ranitidine | Antagonist | 99.9% | Yes |
| HY-B0273 | Sulfadiazine | Inhibitor | 99.89% | Yes |
| HY-112076 | Atropine methyl bromide | Antagonist | 99.84% | Unkown |
| HY-B0281A | Ranitidine hydrochloride | Antagonist | 99.86% | Yes |
| HY-17498R | Atenolol (Standard) | Antagonist | 99.81% | Unkown |
| HY-P0004 | Lysipressin | Activator | 99.22% | Unkown |
| HY-N0340 | Scopolamine butylbromide | Antagonist | 99.97% | Unkown |
| HY-B0595 | Ramosetron Hydrochloride | Antagonist | 99.96% | Unkown |
| HY-70050A | Alosetron | Antagonist | 96.26% | Unkown |
| HY-B0519 | Tylosin tartrate | Inhibitor | 98.0% | Unkown |
| HY-B1042 | Oxolamine citrate | Inhibitor | 99.87% | Unkown |
| HY-B1055 | Pentoxyverine citrate | 99.57% | Unkown | |
| HY-134004 | Pentoxyverine | 99.56% | Unkown | |
| HY-101810 | Tazanolast | Inhibitor | 99.50% | Unkown |
| HY-B0170A | Azatadine dimaleate | Inhibitor | 99.85% | Unkown |
| HY-B0273A | Sulfadiazine sodium | Inhibitor | 98.0% | Yes |
| HY-B0519B | Tylosin phosphate | Inhibitor | 99.27% | Unkown |
| HY-B0487 | Ethisterone | Agonist | 98.02% | Unkown |
| HY-P0004A | Lysipressin acetate | Activator | 99.81% | Unkown |
| HY-B0273R | Sulfadiazine (Standard) | Inhibitor | 99.84% | Unkown |
| HY-121166 | Levobetaxolol | Antagonist | / | Unkown |
| HY-70050CR | Alosetron Hydrochloride (Standard) | Antagonist | / | Unkown |
| HY-B0487R | Ethisterone (Standard) | Agonist | / | Unkown |
| HY-B0693A | Ranitidine bismuth citrate | / | Unkown | |
| HY-B1717 | Oxolamine | Inhibitor | / | Unkown |
| HY-P0004R | Lysipressin (Standard) | Activator | / | Unkown |
| HY-70050 | Alosetron (Hydrochloride(1:X)) | Antagonist | / | Unkown |
| HY-70050B | Alosetron ((Z)-2-butenedioate) | Antagonist | / | Unkown |
| HY-B0170 | Azatadine | Inhibitor | / | Unkown |
| HY-B0170AR | Azatadine dimaleate (Standard) | Inhibitor | / | Unkown |
| HY-B0273AR | Sulfadiazine sodium (Standard) | Inhibitor | / | Unkown |
| HY-B0281AR | Ranitidine hydrochloride (Standard) | Antagonist | / | Unkown |
| HY-G0002 | Lurasidone metabolite 14326 | Antagonist | / | Unkown |
Clinical Phase
Bioactive Molecules
(41)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-18732 | L-NMMA | Inhibitor | 99.43% | Phase 4 |
| HY-13402 | Varespladib | Inhibitor | 99.74% | Phase 3 |
| HY-107384A | Asimadoline hydrochloride | Agonist | 99.57% | Phase 3 |
| HY-109134 | Pizuglanstat | Inhibitor | 99.70% | Phase 3 |
| HY-107384 | Asimadoline | Agonist | 99.36% | Phase 3 |
| HY-109134A | Pizuglanstat hydrate | Inhibitor | / | Phase 3 |
| HY-163061 | Quinotolast | Inhibitor | / | Phase 3 |
| HY-108213 | Inosinic acid | 99.93% | Phase 2 | |
| HY-106840 | L-365260 | Antagonist | 99.85% | Phase 2 |
| HY-13510 | Cutamesine dihydrochloride | Agonist | 98.05% | Phase 2 |
| HY-12887 | Piclamilast | Inhibitor | 99.74% | Phase 2 |
| HY-18099A | S1RA hydrochloride | Antagonist | 99.76% | Phase 2 |
| HY-108213R | Inosinic acid (Standard) | 99.31% | Phase 2 | |
| HY-15039 | SSR240612 | Antagonist | 98.72% | Phase 2 |
| HY-14813 | Cutamesine | Agonist | 99.18% | Phase 2 |
| HY-18099 | S1RA | Antagonist | 98.96% | Phase 2 |
| HY-108213A | Inosinic acid disodiumhydrate(1:2:X) | 99.10% | Phase 2 | |
| HY-18006 | NKP608 | 99.88% | Phase 2 | |
| HY-106103 | Seglitide | Modulator | 99.30% | Phase 2 |
| HY-121156 | Anatibant | Antagonist | / | Phase 2 |
| HY-19443 | UCB-35440 | 99.38% | Phase 2 | |
| HY-101208A | L-694247 TFA | Agonist | / | Phase 2 |
| HY-101236 | ICI 192605 | Antagonist | / | Phase 2 |
| HY-106896 | YM 934 | Activator | / | Phase 2 |
| HY-117283 | rel-Aprikalim | Control | / | Phase 2 |
| HY-136831 | SR2640 | Antagonist | / | Phase 2 |
| HY-16765 | Axelopran | Antagonist | / | Phase 2 |
| HY-19249 | Z-335 sodium | Antagonist | / | Phase 2 |
| HY-19252 | GR-4991W93 | Agonist | / | Phase 2 |
| HY-19403 | TKA-731 | Antagonist | / | Phase 2 |
| HY-114724 | HSR-609 | / | Phase 2 | |
| HY-115831 | SAR247799 | Agonist | 99.38% | Phase 1 |
| HY-124410 | Mitoquinol | 98.00% | Phase 1 | |
| HY-139589 | Zaloglanstat | 98.50% | Phase 1 | |
| HY-19393 | SCH 351591 | Inhibitor | 99.22% | Phase 1 |
| HY-19261 | T-0632 | Antagonist | 99.88% | Phase 1 |
| HY-100164 | SDZ-MKS 492 | Inhibitor | 99.77% | Phase 1 |
| HY-115877 | GDC-0334 | Antagonist | / | Phase 1 |
| HY-124959 | Spiradoline mesylate | Agonist | 99.95% | Phase 1 |
| HY-19108 | CI-959 | Inhibitor | / | Phase 1 |
| HY-19109 | RG-7152 | Antagonist | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(499)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-50202 | Etomoxir | 99.58% | Yes | |
| HY-P2974 | Elastase, Porcine pancreas | / | Unkown | |
| HY-50202A | Etomoxir sodium salt | 99.62% | Yes | |
| HY-P1635 | Pepsin | / | Unkown | |
| HY-19989 | MK-571 | 98.85% | Unkown | |
| HY-Y1168 | DMTMM | 99.53% | Unkown | |
| HY-B2060A | Tiamulin fumarate | Inhibitor | 99.27% | Unkown |
| HY-103447 | Zearalenone | Activator | 98.95% | Unkown |
| HY-15754 | CGP37157 | Inhibitor | 99.87% | Unkown |
| HY-19989A | MK-571 sodium | 99.75% | Unkown | |
| HY-113449 | Ubiquinone-1 | Substrate | 99.0% | Unkown |
| HY-111925 | BI-749327 | Antagonist | 99.95% | Unkown |
| HY-101369 | BW-723C86 | Agonist | 99.74% | Unkown |
| HY-101044 | PPADS tetrasodium | 99.9% | Unkown | |
| HY-P2831 | Esterase, pig liver | / | Unkown | |
| HY-P3479 | Insulin (swine) | 99.90% | Unkown | |
| HY-121238 | Hyocholic acid | 99.46% | Unkown | |
| HY-106301 | Devazepide | Antagonist | 99.55% | Unkown |
| HY-122502 | Pyrazofurin | Inhibitor | ≥98.0% | Unkown |
| HY-Y0488A | Formic acid ammonium | 98.47% | Unkown | |
| HY-128965 | N-Glycolylneuraminic acid | 99.76% | Unkown | |
| HY-B2060 | Tiamulin | Inhibitor | 99.74% | Unkown |
| HY-101408 | Docosatrienoic Acid | 99.9% | Unkown | |
| HY-106369 | HMR 1556 | Inhibitor | 99.95% | Unkown |
| HY-117040 | nor-Binaltorphimine | Antagonist | 98.70% | Unkown |
| HY-N6678 | Zearalanone | 99.60% | Unkown | |
| HY-P0242A | Neurokinin B TFA | Agonist | 99.36% | Unkown |
| HY-B0905 | Tilmicosin | 98.0% | Unkown | |
| HY-90002 | 4-Phenylpiperidine | Ligand | 99.9% | Unkown |
| HY-E70198 | Pepsin (MS Grade) | / | Unkown | |
| HY-101341 | RS 67333 hydrochloride | Agonist | 99.68% | Unkown |
| HY-101327A | Xamoterol hemifumarate | Agonist | ≥99.0% | Unkown |
| HY-W017758 | 1,3-Propanediol | 99.97% | Unkown | |
| HY-135108 | QWF Peptide | Antagonist | 98.51% | Unkown |
| HY-15744 | LY255283 | Antagonist | 98.04% | Unkown |
| HY-121799A | Taurohyocholic acid sodium salt | 98.08% | Unkown | |
| HY-133091 | 7-Ethoxycoumarin | 99.84% | Unkown | |
| HY-13283 | MF63 | Inhibitor | 99.55% | Unkown |
| HY-150270A | NP-1815-PX sodium | 99.51% | Unkown | |
| HY-N2424 | Flavone | 99.85% | Unkown | |
| HY-N6821 | 2-O-α-D-Glucopyranosyl-L-ascorbic Acid | 99.81% | Unkown | |
| HY-P1192 | GR-73632 | Agonist | 99.89% | Unkown |
| HY-103197 | 2-Methoxyidazoxan monohydrochloride | Antagonist | 98.62% | Unkown |
| HY-108591 | L-364,373 | Activator | 99.65% | Unkown |
| HY-106961 | ONO 1301 | Agonist | 99.02% | Unkown |
| HY-P10927 | BRP | 95.15% | Unkown | |
| HY-Y0047 | 3-Picolylamine | 99.73% | Unkown | |
| HY-108511 | PB28 dihydrochloride | 99.63% | Unkown | |
| HY-137243 | Adenosine 3',5'-diphosphate disodium | Inhibitor | 99.12% | Unkown |
| HY-N0165 | Methyl-Hesperidin | 98.29% | Unkown | |
| HY-156684 | Nedizantrep | Inhibitor | 99.56% | Unkown |
| HY-W013762 | Tributyl citrate | 98.33% | Unkown | |
| HY-17498S | Atenolol-d7 | Antagonist | 99.62% | Unkown |
| HY-W133891 | Peptone from soya | / | Unkown | |
| HY-101005 | N-Methylhistamine dihydrochloride | 99.99% | Unkown | |
| HY-B2162C | Chondroitin sulfate (from pig) | 95.06% | Unkown | |
| HY-P1256C | JMV 449 acetate | Agonist | 99.69% | Unkown |
| HY-Y1217 | 1-Cyclohexanol | 99.94% | Unkown | |
| HY-131605B | Ganciclovir triphosphate disodium solution (100 mM ± 3 mM) | Inhibitor | 98.65% | Unkown |
| HY-B1340 | Carbadox | Inhibitor | 98.0% | Unkown |
| HY-19699 | 1-Naphthylacetamide | / | Unkown | |
| HY-13402A | Varespladib sodium | Inhibitor | 98.83% | Yes |
| HY-14336A | SB 271046 Hydrochloride | Antagonist | 99.93% | Unkown |
| HY-121638A | (5Z,2E)-CU-3 | 95.03% | Unkown | |
| HY-125339 | Ro 41-0960 | 98.22% | Unkown | |
| HY-N0352 | Tuberostemonine | Inhibitor | 99.86% | Unkown |
| HY-N2255 | Crebanine | 99.83% | Unkown | |
| HY-101396 | ICA-069673 | Activator | 99.20% | Unkown |
| HY-16915 | RPR-260243 | Activator | 99.37% | Unkown |
| HY-101222 | SB-203186 hydrochloride | Antagonist | 99.94% | Unkown |
| HY-121156A | Anatibant hydrochloride | Antagonist | 99.44% | Unkown |
| HY-141582 | Ceramide 3 | Inhibitor | 98.0% | Unkown |
| HY-P1015 | VIP(Guinea pig) | Ligand | 98.66% | Unkown |
| HY-P1096 | A71623 | Agonist | 99.34% | Unkown |
| HY-W010056 | Diethyl fumarate | Inducer | 98.97% | Unkown |
| HY-101325 | (S,S)-BRL-37344 sodium | 99.90% | Unkown | |
| HY-101325A | (S,S)-BRL-37344 | 99.45% | Unkown | |
| HY-103149 | SB-216641A | Antagonist | 98.04% | Unkown |
| HY-136661 | (-)-N6-Phenylisopropyl adenosine | Agonist | 99.45% | Unkown |
| HY-B0905A | Tilmicosin phosphate | Inhibitor | 98.0% | Unkown |
| HY-108594 | PD-118057 | Activator | ≥99.0% | Unkown |
| HY-50723 | 3-Methylxanthine | 99.45% | Unkown | |
| HY-B1421 | Ractopamine hydrochloride | Agonist | 99.2% | Unkown |
| HY-101232 | Tiotidine | Antagonist | 99.28% | Unkown |
| HY-101765 | GW 833972A | Agonist | 99.91% | Unkown |
| HY-145154 | Digoxigenin monodigitoxoside | 98.0% | Unkown | |
| HY-N1750 | 3-(2,4-Dihydroxyphenyl)propanoic acid | Inhibitor | 99.46% | Unkown |
| HY-P2317 | Cecropin P1, porcine | Inhibitor | 99.83% | Unkown |
| HY-W702001 | Avizafone dihydrobromide | / | Unkown | |
| HY-Y0032 | Thiosemicarbazide | Inhibitor | 99.91% | Unkown |
| HY-D0808 | Meldola blue | / | Unkown | |
| HY-N10620 | Melitidin | 98.63% | Unkown | |
| HY-W020246 | Tetramethylthiuram monosulfide | Inhibitor | 99.71% | Unkown |
| HY-50723R | 3-Methylxanthine (Standard) | 99.58% | Unkown | |
| HY-N12520 | Helveticoside | 95.20% | Unkown | |
| HY-135976 | P2X3 antagonist 34 | Antagonist | 99.44% | Unkown |
| HY-101231 | ICI-204448 | 98.09% | Unkown | |
| HY-103447R | Zearalenone (Standard) | Activator | 98.85% | Unkown |
| HY-103447S1 | Zearalenone-13C18 | 98.7% | Unkown | |
| HY-123068 | Captopril disulfide | 99.29% | Unkown | |
| HY-19664 | Pranidipine | Inhibitor | 99.52% | Unkown |
| HY-P10768A | Ro 25-1553 TFA | Agonist | 99.17% | Unkown |
| HY-P1112 | Sarafotoxin S6a | Agonist | 98.59% | Unkown |
| HY-N2106 | Dehydroevodiamine | Inhibitor | 98.55% | Unkown |
| HY-Y0850U3 | PVA (Mw 125000, 98-99% hydrolyzed, ~2800 polymerization) | / | Unkown | |
| HY-116326 | BayCysLT2 | Antagonist | 97.7% | Unkown |
| HY-123596 | LAS191859 | Antagonist | 99.93% | Unkown |
| HY-167902 | YM-31636 free base | Agonist | 99.05% | Unkown |
| HY-59132 | 2-Amino-1-phenylethanol | 98.36% | Unkown | |
| HY-N10424 | Brazilein | 99.9% | Unkown | |
| HY-P1494 | Substance P (1-9) | 99.48% | Unkown | |
| HY-101167 | Aminopotentidine | Antagonist | 98.54% | Unkown |
| HY-137325A | 2-Chloro-ATP sodium | 98.41% | Unkown | |
| HY-149589 | 11(Z),14(Z)-Eicosadienoic acid | Inhibitor | ≥98.0% | Unkown |
| HY-156978 | Ritolukast | Antagonist | 99.92% | Unkown |
| HY-B1870 | Metaldehyde | 98.0% | Unkown | |
| HY-N3198A | Sophoramine | Inhibitor | 99% | Unkown |
| HY-W420033 | (S)-(+)-Etomoxir | 98.65% | Unkown | |
| HY-B0273S | Sulfadiazine-d4 | Inhibitor | 99.31% | Unkown |
| HY-16765A | Axelopran sulfate | Antagonist | 99.14% | Unkown |
| HY-101390 | (+)-Niguldipine hydrochloride | Ligand | 98.06% | Unkown |
| HY-106840A | L-365260 hemihydrate | Antagonist | 99.75% | Unkown |
| HY-106961A | (Z)-ONO 1301 | Agonist | 98.13% | Unkown |
| HY-121495 | BKI-1369 | Inhibitor | 99.37% | Unkown |
| HY-12709A | ARC 239 dihydrochloride | Antagonist | 99.20% | Unkown |
| HY-134116 | Isoflupredone acetate | 98.55% | Unkown | |
| HY-E70231 | Thrombin-like enzyme | / | Unkown | |
| HY-P1016B | BQ-3020 ammonium | Agonist | 98.96% | Unkown |
| HY-P10927A | BRP TFA | / | Unkown | |
| HY-W130596 | 3-Phenylpropyl acetate | 99.37% | Unkown | |
| HY-W145481A | D-Galacto-D-mannan | / | Unkown | |
| HY-101676 | RG-12525 | 98.31% | Unkown | |
| HY-108213S1 | Inosinic acid-15N4 dilithium | 98.0% | Unkown | |
| HY-120927A | Alvimopan metabolite hydrochloride | Antagonist | 99.93% | Unkown |
| HY-B1133 | Sulbentine | Inhibitor | 99.37% | Unkown |
| HY-B1849 | Hexazinone | 99.95% | Unkown | |
| HY-RS29454 | UBE2E1 Pig Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS29455 | UBE2E2 Pig Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-103089 | LY393558 | Antagonist | 99.0% | Unkown |
| HY-138646 | Poly(deoxyadenylic-thymidylic) acid sodium | / | Unkown | |
| HY-101327 | Xamoterol | Agonist | / | Unkown |
| HY-101343 | RS 39604 | Antagonist | 98.0% | Unkown |
| HY-103158 | BW B70C | Inhibitor | / | Unkown |
| HY-103304 | SB 268262 | 99.9% | Unkown | |
| HY-103447S | (Rac)-Zearalenone-d6 | 94.44% | Unkown | |
| HY-10419 | AH23848 | Inhibitor | / | Unkown |
| HY-105872 | Trifenagrel | Inhibitor | 99.35% | Unkown |
| HY-107610 | SR2640 hydrochloride | Antagonist | 99.41% | Unkown |
| HY-107647A | (R)-(+)-Dimethindene maleate | Antagonist | 99.50% | Unkown |
| HY-123801 | MIDD0301 | Modulator | 98.14% | Unkown |
| HY-129101 | (-)-Eseroline fumarate | Antagonist | 98.03% | Unkown |
| HY-131605 | Ganciclovir triphosphate | Inhibitor | / | Unkown |
| HY-13213 | AM211 | Antagonist | 98.79% | Unkown |
| HY-134092 | N-Methyl Leukotriene C4 | Agonist | 98.1% | Unkown |
| HY-136587 | Oxomemazine | Antagonist | 99.18% | Unkown |
| HY-148144A | Clobutinol hydrochloride | Inhibitor | 99.86% | Unkown |
| HY-15264 | MC 1046 | Activator | 91.48% | Unkown |
| HY-15791 | FR173657 | Antagonist | / | Unkown |
| HY-163101 | CP-96021 | Antagonist | 98.04% | Unkown |
| HY-169450 | (-)-9-Hydroxycorynantheidine | Agonist | 99.2% | Unkown |
| HY-185345 | GR119566X | Ligand | / | Unkown |
| HY-45509 | TLB 150 Benzoate | Modulator | 98.3% | Unkown |
| HY-N8276 | Ro 3-1314 | Inhibitor | 99.0% | Unkown |
| HY-P0263A | Dermaseptin TFA | Inhibitor | 99.21% | Unkown |
| HY-P2289A | β-defesin 1 (pig) TFA | Inhibitor | 99.11% | Unkown |
| HY-P2995A | Hemoglobin porcine | / | Unkown | |
| HY-P3895A | Substance P (3-11) acetate | / | Unkown | |
| HY-P4405 | (D-Ala2)-GRF (1-29) amide (human) | Agonist | 98.83% | Unkown |
| HY-W1135843 | ARN-75039 | Inhibitor | / | Unkown |
| HY-101208 | L-694247 | Agonist | 99.9% | Unkown |
| HY-116778 | Prostaglandin G2 | Inducer | 99.9% | Unkown |
| HY-141582S | Ceramide 3-d3 | Inhibitor | 98.0% | Unkown |
| HY-149942 | PAP-IN-1 | Inhibitor | / | Unkown |
| HY-185345A | GR119566X dihydrochloride | Ligand | / | Unkown |
| HY-19102 | NSP-805 | Inhibitor | 99.28% | Unkown |
| HY-50202R | Etomoxir (Standard) | 99.56% | Unkown | |
| HY-B0519AS | Tylosin-d3 | Inhibitor | 97.42% | Unkown |
| HY-B1136 | Menbutone | 99.94% | Unkown | |
| HY-D2337 | Quinophthalone | / | Unkown | |
| HY-P2841 | Elastin from pig | / | Unkown | |
| HY-W087907 | Acetylsalicylsalicylic acid | 99.24% | Unkown | |
| HY-125790 | Cyclazocine | Modulator | / | Unkown |
| HY-151198 | CHF-6366 | / | Unkown | |
| HY-165443 | Cassaine | Inhibitor | / | Unkown |
| HY-165504 | Nagstatin | Inhibitor | / | Unkown |
| HY-100254 | TAK-024 | Inhibitor | / | Unkown |
| HY-100481 | RP 72540 | Antagonist | / | Unkown |
| HY-100724 | YM-17690 | Agonist | / | Unkown |
| HY-101225 | 8 Hydroxy PIPAT oxalate | / | Unkown | |
| HY-101235 | ICI 185282 | Antagonist | / | Unkown |
| HY-101325B | BRL-37344 | Agonist | / | Unkown |
| HY-101342 | RS 67506 hydrochloride | Agonist | / | Unkown |
| HY-101390A | (-)-Niguldipine hydrochloride | Antagonist | / | Unkown |
| HY-101390D | (R)-Niguldipine | Antagonist | / | Unkown |
| HY-101590A | Symetine dihydrochloride | Inhibitor | / | Unkown |
| HY-101670 | MTPPA | Inhibitor | 99.82% | Unkown |
| HY-103143A | SDZ 205-557 | Antagonist | / | Unkown |
| HY-103296 | Bombinakinin M | Agonist | / | Unkown |
| HY-103447R1 | Zearalenone in Acetonitrile (Standard) | Activator | / | Unkown |
| HY-10382 | EXP-6803 | Antagonist | / | Unkown |
| HY-10419A | AH23848 hemicalcium salt | Inhibitor | 97.0% | Unkown |
| HY-105030 | Tioxamast | / | Unkown | |
| HY-105138 | (6R)-Naxifylline | Antagonist | / | Unkown |
| HY-105215 | FK888 | Antagonist | / | Unkown |
| HY-105334A | Dilopetine citrate | / | Unkown | |
| HY-105358 | CP-288886 | Antagonist | / | Unkown |
| HY-105572 | Moveltipril calcium | / | Unkown | |
| HY-106049 | Acrihellin | / | Unkown | |
| HY-106076 | REV 2871 | Inhibitor | / | Unkown |
| HY-106756 | Spiradoline | Agonist | / | Unkown |
| HY-107018 | AR-A 2 | Antagonist | / | Unkown |
| HY-107062 | AA 344 | / | Unkown | |
| HY-107563 | ROS 234 | Antagonist | / | Unkown |
| HY-107563A | ROS 234 dioxalate | Antagonist | / | Unkown |
| HY-107564 | Impentamine dihydrobromide | Inhibitor | / | Unkown |
| HY-107611 | Ro 24-5913 | Antagonist | / | Unkown |
| HY-107644 | AQ-RA 741 | Antagonist | / | Unkown |
| HY-108511A | PB28 | / | Unkown | |
| HY-108561 | L-670596 | Antagonist | / | Unkown |
| HY-109023 | Azeloprazole | / | Unkown | |
| HY-111918 | A71378 | Agonist | / | Unkown |
| HY-112739 | SC-41930 | Agonist | / | Unkown |
| HY-112742 | CP-195543 | Antagonist | 98.86% | Unkown |
| HY-113442A | 6-trans-Leukotriene B4 | / | Unkown | |
| HY-113465A | 11-trans Leukotriene E4 | / | Unkown | |
| HY-113693 | ONO-RS-347 | Antagonist | / | Unkown |
| HY-113695 | BW A575C | Inhibitor | / | Unkown |
| HY-113727 | SC-39070 | Antagonist | / | Unkown |
| HY-113758 | LY 163443 | Antagonist | / | Unkown |
| HY-113781 | Ractopamine | Agonist | / | Unkown |
| HY-113781S | Ractopamine-d6 | Agonist | / | Unkown |
| HY-113829 | Valnemulin | Inhibitor | 99.0% | Unkown |
| HY-113841 | RS-87337 | Inhibitor | / | Unkown |
| HY-114538 | Asobamast | / | Unkown | |
| HY-114660 | 9,11-Methane-epoxy prostaglandin F1α | / | Unkown | |
| HY-114723 | NPD9948 | / | Unkown | |
| HY-114743 | GS 283 | Antagonist | / | Unkown |
| HY-114751 | 16,16-Dimethylprostaglandin E1 | / | Unkown | |
| HY-114792 | 15-Methylprostaglandin E1 | / | Unkown | |
| HY-114920 | Piprofurol | Inhibitor | / | Unkown |
| HY-116033 | BMS-363131 | Inhibitor | / | Unkown |
| HY-116042 | FSCPX | Antagonist | 99.72% | Unkown |
| HY-116051 | 16,16-Dimethylprostaglandin F2α | / | Unkown | |
| HY-116268 | GSK256471 | Inhibitor | / | Unkown |
| HY-116400 | BN 50341 | Antagonist | / | Unkown |
| HY-116586 | AF710B | / | Unkown | |
| HY-116591 | 8-Iso-15-keto prostaglandin F2β | / | Unkown | |
| HY-116638 | AHR-5333 | Inhibitor | / | Unkown |
| HY-116638A | AHR-5333 mandelate | Inhibitor | / | Unkown |
| HY-117811 | (R,R)-MK 287 | Inhibitor | / | Unkown |
| HY-117842 | KY 234 | Inhibitor | / | Unkown |
| HY-117896 | SC-50605 | Antagonist | / | Unkown |
| HY-117952 | L 743310 | Antagonist | / | Unkown |
| HY-118033 | SQ 30774 | Inhibitor | / | Unkown |
| HY-118185 | SQ 31844 | Inhibitor | / | Unkown |
| HY-118220 | EP 171 | Agonist | / | Unkown |
| HY-118350 | FR 75513 | / | Unkown | |
| HY-118463 | Benzomalvin A | / | Unkown | |
| HY-118546 | JNJ-17156516 | Antagonist | / | Unkown |
| HY-118674 | AK-2-38 | Antagonist | / | Unkown |
| HY-118834 | Teleocidin A1 | Activator | / | Unkown |
| HY-118945 | FR191413 | / | Unkown | |
| HY-119238 | CRL-42872 | Inhibitor | / | Unkown |
| HY-119908 | Hetramine | Inhibitor | / | Unkown |
| HY-120302 | PD 140376 | Antagonist | / | Unkown |
| HY-120355 | AP14145 | Inhibitor | / | Unkown |
| HY-120418 | L-687306 | Agonist | / | Unkown |
| HY-120688 | L-772405 | Agonist | / | Unkown |
| HY-120915 | L 689660 maleate | Agonist | / | Unkown |
| HY-120955 | (+)-5-trans Cloprostenol | Control | / | Unkown |
| HY-121007 | Bepafant | Antagonist | / | Unkown |
| HY-121164 | GSK172981 | Antagonist | / | Unkown |
| HY-121183 | Aprikalim | Activator | / | Unkown |
| HY-121520 | Docosahexaenoyl glycine | Activator | / | Unkown |
| HY-121621 | RO5101576 | / | Unkown | |
| HY-122409 | Cularine | / | Unkown | |
| HY-122557 | AZD3676 | Ligand | / | Unkown |
| HY-12299G | WH-4-023 (GMP) | Inhibitor | / | Unkown |
| HY-123013 | Y 9000 | / | Unkown | |
| HY-123189 | LY 171859 | / | Unkown | |
| HY-123193 | Avizafone | / | Unkown | |
| HY-123206 | R-96544 free base | Antagonist | / | Unkown |
| HY-123459 | Garomefrine (hydrochlorid) | / | Unkown | |
| HY-123480A | EGIS-7625 free base | Antagonist | / | Unkown |
| HY-123497 | R116031 | Antagonist | / | Unkown |
| HY-124410S | Mitoquinol-d15 | Inhibitor | / | Unkown |
| HY-126569 | Efrotomycin | Inhibitor | 83.42% | Unkown |
| HY-126862 | AQ-RA 721 | Antagonist | / | Unkown |
| HY-128043 | 11-Deoxy prostaglandin E1 | / | Unkown | |
| HY-128965R | N-Glycolylneuraminic acid (Standard) | / | Unkown | |
| HY-129448 | RO4583298 | Antagonist | / | Unkown |
| HY-130138A | (5S,6R)-DiHETE | Activator | / | Unkown |
| HY-130138B | (5S,6R)-DiHETEs | Control | / | Unkown |
| HY-131696 | 11-deoxy Prostaglandin F1α | Control | / | Unkown |
| HY-13402S | Varespladib-d7 | / | Unkown | |
| HY-13511AS | Rupatadine-d4 fumarate | / | Unkown | |
| HY-135439 | SB-203186 | Antagonist | / | Unkown |
| HY-136634 | BTM-1042 | Inhibitor | / | Unkown |
| HY-136677 | Lnd 796 | Agonist | / | Unkown |
| HY-139112 | Leukotriene B4 dimethyl amide | / | Unkown | |
| HY-14297 | Milveterol | / | Unkown | |
| HY-14300D | Vilanterol acetate | Agonist | / | Unkown |
| HY-147014 | Cyclic HPMPC | Inhibitor | / | Unkown |
| HY-148038 | 5-HT3 antagonist 5 | Antagonist | 99.75% | Unkown |
| HY-148144 | Clobutinol | Inhibitor | / | Unkown |
| HY-14939A | Vapitadine hydrochloride | Antagonist | / | Unkown |
| HY-151413A | MEN 10207 acetate | Antagonist | / | Unkown |
| HY-157796 | β2AR agonist 4 | Agonist | / | Unkown |
| HY-159196 | 1α,25-Dihydroxy-24-oxocholecalciferol | / | Unkown | |
| HY-159750 | M903 | Activator | / | Unkown |
| HY-163702 | CHF-6550 | / | Unkown | |
| HY-164010 | SUN-1334H free base | Inhibitor | / | Unkown |
| HY-164650 | Pirodomast | Inhibitor | / | Unkown |
| HY-165498 | AU-461 | Inhibitor | / | Unkown |
| HY-165555 | MMV665917 | Inhibitor | / | Unkown |
| HY-169430 | AGU654 | Inhibitor | / | Unkown |
| HY-169867 | BNTX | Antagonist | / | Unkown |
| HY-170918 | BKCa activator-1 | Activator | / | Unkown |
| HY-171794 | AZD1134 | Antagonist | / | Unkown |
| HY-17498B | Atenolol hydrochloride | Antagonist | / | Unkown |
| HY-176524S | PDE3/4-IN-3 | Inhibitor | / | Unkown |
| HY-177311 | NVP-QBE170 | Inhibitor | / | Unkown |
| HY-180363 | E 6080 | Inhibitor | / | Unkown |
| HY-180365 | GW 833972A free base | Agonist | / | Unkown |
| HY-180376 | TAC 363 | Antagonist | / | Unkown |
| HY-180401 | DMP 811 | Antagonist | / | Unkown |
| HY-180411 | SM-15178 | Antagonist | / | Unkown |
| HY-18060B | Bradanicline tosylate | Agonist | / | Unkown |
| HY-181770 | PDE4B-IN-7 | Inhibitor | / | Unkown |
| HY-182252 | SAR296968 | Inhibitor | / | Unkown |
| HY-182296 | SCH 79687 | Antagonist | / | Unkown |
| HY-182393 | IGN-2098 | Antagonist | / | Unkown |
| HY-182422 | CGS 23885 | Inhibitor | / | Unkown |
| HY-182423 | RO5328673 | Antagonist | / | Unkown |
| HY-182427 | ORF 17583 | Antagonist | / | Unkown |
| HY-182434 | CL 118326 | / | Unkown | |
| HY-182440 | AZD3783 | Antagonist | / | Unkown |
| HY-182515 | U-19052 | Antagonist | / | Unkown |
| HY-182557 | KC-11404 | Inhibitor | / | Unkown |
| HY-182563 | Tyr-Ala-N-(1,3-dimethylbutyl)glycinamide | Ligand | / | Unkown |
| HY-182585 | Berupipam | Antagonist | / | Unkown |
| HY-182599 | RCC-36 hydrochloride | / | Unkown | |
| HY-182625 | GS-1160-180 | Antagonist | / | Unkown |
| HY-182635 | ICI 147798 | Antagonist | / | Unkown |
| HY-182640 | SM-11044 | Agonist | / | Unkown |
| HY-182646 | NE-10133 | Inhibitor | / | Unkown |
| HY-182680 | Manoalogue | Inhibitor | / | Unkown |
| HY-182696 | CGS 24891 | Inhibitor | / | Unkown |
| HY-182701 | 5-HT3 antagonist-7 | Antagonist | / | Unkown |
| HY-183206 | UR 8225 | / | Unkown | |
| HY-183334 | TDP1-IN-5 | / | Unkown | |
| HY-185123 | Pig TRIM56 mRNA | / | Unkown | |
| HY-19042 | YM-16638 | Antagonist | / | Unkown |
| HY-19259 | GP3269 | Inhibitor | / | Unkown |
| HY-19395 | MEN-91507 | Antagonist | / | Unkown |
| HY-19633A | CS-003 | / | Unkown | |
| HY-A0168S | Regadenoson-d3 | Agonist | / | Unkown |
| HY-B0204B | (-)-Pimobendan | Control | / | Unkown |
| HY-B0273S1 | Sulfadiazine-13C6 | Inhibitor | 99.18% | Unkown |
| HY-B0693S | Ranitidine-d6 | / | Unkown | |
| HY-B0905S | Tilmicosin-d3 | 98.9% | Unkown | |
| HY-B1340S | Carbadox-d3 | Inhibitor | / | Unkown |
| HY-B1421S | Ractopamine-d6 hydrochloride | / | Unkown | |
| HY-B1421S1 | Ractopamine-d9 hydrochloride | / | Unkown | |
| HY-B1421S3 | Ractopamine-d5 hydrochloride | / | Unkown | |
| HY-B1717A | Oxolamine hydrochloride | Inhibitor | / | Unkown |
| HY-D3485 | Dexamethasone fluorescein | / | Unkown | |
| HY-E70197 | Calpain-1 (pig) | / | Unkown | |
| HY-E70245 | Cholyl-CoA | / | Unkown | |
| HY-E70394 | S-Acetonyl-CoA | Inhibitor | / | Unkown |
| HY-E70437 | Guinea pig liver transglutaminase | / | Unkown | |
| HY-N11727 | Boeravinone F | / | Unkown | |
| HY-N11738 | Aspalathin | / | Unkown | |
| HY-N12108 | Forphenicine | Inhibitor | / | Unkown |
| HY-N16449 | Arachidonoylmorpholine | / | Unkown | |
| HY-N17361 | Methylgerambullone | / | Unkown | |
| HY-N17617 | S-Petasin | / | Unkown | |
| HY-N18266 | 10-Hydroxycroomine | / | Unkown | |
| HY-N19128 | Pulchinenoside J | Inhibitor | / | Unkown |
| HY-N3167 | Nyasicoside | / | Unkown | |
| HY-N3931 | Gardneramine | / | Unkown | |
| HY-NP002M | Guinea Pig serum albumin | / | Unkown | |
| HY-NP015 | SLT/SLT-IIe (O139) protein | Inducer | / | Unkown |
| HY-NP0216 | Guinea pig Immunoglobulin G | / | Unkown | |
| HY-NP036 | Pig Insulin-PE | / | Unkown | |
| HY-P10006 | Leumorphin, human | Agonist | / | Unkown |
| HY-P1015A | VIP(Guinea pig) TFA | Ligand | / | Unkown |
| HY-P1016 | BQ-3020 | Antagonist | / | Unkown |
| HY-P10291 | [Pro34]Neuropeptide Y, porcine | Agonist | / | Unkown |
| HY-P10599 | Scyliorhinin I | Agonist | / | Unkown |
| HY-P1112A | Sarafotoxin S6a TFA | Agonist | / | Unkown |
| HY-P1256 | JMV 449 | Agonist | / | Unkown |
| HY-P1994A | JMV 170 | Agonist | / | Unkown |
| HY-P2015 | Diacetylsplenopentine | Inhibitor | / | Unkown |
| HY-P2015A | Diacetylsplenopentin hydrochloride | Inhibitor | / | Unkown |
| HY-P2289 | β-defesin 1 (pig) | Inhibitor | / | Unkown |
| HY-P2291 | Beta-defensin 103 isoform X1, pig | Inhibitor | / | Unkown |
| HY-P2291A | Beta-defensin 103 isoform X1, pig TFA | Inhibitor | / | Unkown |
| HY-P2317A | Cecropin P1, porcine acetate | Inhibitor | / | Unkown |
| HY-P2601A | Tyr-α-CGRP (human) TFA | / | Unkown | |
| HY-P2703 | Peptide YY (pig) | Activator | / | Unkown |
| HY-P2807J | L-Lactate Dehydrogenase (L-LDH), pig muscle | / | Unkown | |
| HY-P2995E | Guinea Pig Hemoglobin | / | Unkown | |
| HY-P3057 | [D-Trp11]-Neurotensin | Modulator | / | Unkown |
| HY-P3563 | [Lys4] Sarafotoxin S6c | Agonist | / | Unkown |
| HY-P3629 | Dynorphin B 29 (pig) | / | Unkown | |
| HY-P3809 | [D-Pro2,D-Phe7,D-Trp9] Substance P | / | Unkown | |
| HY-P3895 | Substance P (3-11) | / | Unkown | |
| HY-P3896 | Substance P (2-11) | / | Unkown | |
| HY-P5769 | Endothelin (16-21) | Agonist | / | Unkown |
| HY-RS10501 | PIGS Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-U00049A | Mioflazine (di(hydrochloride) hydrate) | Antagonist | / | Unkown |
| HY-U00049B | Mioflazine dihydrochloride | Antagonist | / | Unkown |
| HY-W102356R | Phenethyl acetate (Standard) | / | Unkown | |
| HY-W102356S | Phenethyl acetate-d3 | / | Unkown | |
| HY-W1121873 | β-Caryophyllene alcohol | / | Unkown | |
| HY-W127485 | cis-9,10-Methyleneoctadecanoic Acid | / | Unkown | |
| HY-W747554 | SM 32 | / | Unkown | |
| HY-W747563 | 11-trans Leukotriene D4 | / | Unkown | |
| HY-W751275 | Ractopamine-13C2 | Agonist | / | Unkown |
| HY-W751276 | Ractopamine-13C6 | Agonist | / | Unkown |
| HY-W766130 | Ethisterone-13C2 | / | Unkown | |
| HY-W766292A | Androst-16-en-3β-ol | / | Unkown | |
| HY-W766785 | Tiamulin Fumarate-13C4 | / | Unkown | |
| HY-W769319 | Inosinic acid-13C5 | / | Unkown | |
| HY-W769319A | Inosinic acid-13C5 TEA | / | Unkown | |
| HY-W834690 | G6Pase catalytic enzyme-IN-1 | Inhibitor | / | Unkown |
| HY-Y0047S | 3-Picolylamine-d2 | / | Unkown | |
| HY-101327AR | Xamoterol hemifumarate (Standard) | Agonist | / | Unkown |
| HY-101724 | ReN-1869 hydrochloride | Antagonist | / | Unkown |
| HY-101749 | WAY127093B racemate | Inhibitor | / | Unkown |
| HY-103143 | SDZ 205-557 hydrochloride | Antagonist | / | Unkown |
| HY-103447S2 | Zearalenone-13C7 | Activator | / | Unkown |
| HY-106150 | Eniporide | Inhibitor | / | Unkown |
| HY-106514 | Prifelone | Inhibitor | / | Unkown |
| HY-106699 | Taprostene sodium | Agonist | / | Unkown |
| HY-106831 | R 56865 | Inhibitor | / | Unkown |
| HY-115381 | Lipoxin A5 | / | Unkown | |
| HY-116606 | LY108742 | Antagonist | / | Unkown |
| HY-116680 | LY53857 | Antagonist | / | Unkown |
| HY-117255 | ZM260384 | / | Unkown | |
| HY-117557 | LY306669 | Antagonist | / | Unkown |
| HY-117706 | LY 292728 | Antagonist | / | Unkown |
| HY-117717 | (Rac)-SC-31391 | Activator | / | Unkown |
| HY-117862 | TASP0412098 | / | Unkown | |
| HY-118378 | ZD6021 | Antagonist | / | Unkown |
| HY-118444 | (Rac)-WRC-0571 | Antagonist | / | Unkown |
| HY-118647 | Ditophal | Inhibitor | / | Unkown |
| HY-119167 | Lotifazole | / | Unkown | |
| HY-119883 | A-61603 (free base） | Agonist | / | Unkown |
| HY-120476 | JNJ-39729209 | Inhibitor | / | Unkown |
| HY-121763 | SCH-43478 | Inhibitor | / | Unkown |
| HY-123801A | MIDD0301 sodium | Inhibitor | / | Unkown |
| HY-126063 | ICI-204448 free acid | / | Unkown | |
| HY-128510 | Colterol | Agonist | / | Unkown |
| HY-128510A | Colterol hydrochloride | Agonist | / | Unkown |
| HY-129516 | A-70874 | Agonist | / | Unkown |
| HY-129785 | CP-220629 | Inhibitor | / | Unkown |
| HY-13213A | AM211 sodium | Antagonist | / | Unkown |
| HY-135568 | CRL-42872 free base | Inhibitor | / | Unkown |
| HY-138110 | Toladryl | Antagonist | 97.23% | Unkown |
| HY-15718B | Istaroxime oxalate | Inhibitor | / | Unkown |
| HY-160932 | RS-15385-198 | / | Unkown | |
| HY-165493 | Opc-15161 | / | Unkown | |
| HY-165524 | AM 92016 | Inhibitor | / | Unkown |
| HY-167129 | DBO-83 free base | Agonist | / | Unkown |
| HY-167689 | Parethoxycaine hydrochloride | / | Unkown | |
| HY-169472 | 11-Deoxy prostaglandin F1β | / | Unkown | |
| HY-169872 | 17-Hydroxystearic acid | / | Unkown | |
| HY-171000 | Propiverine N-oxide | / | Unkown | |
| HY-17498S1 | Atenolol-d6 | / | Unkown | |
| HY-17498S3 | Atenolol-13C6 | Antagonist | / | Unkown |
| HY-175102 | Lyso-globotetraosylceramide (d18:1) | / | Unkown | |
| HY-183859 | H142/08 | Agonist | / | Unkown |
| HY-183921 | SQ 32547 | Inhibitor | / | Unkown |
| HY-183932 | NPC-14695 | Antagonist | / | Unkown |
| HY-183954 | MDL-19744A | Antagonist | / | Unkown |
| HY-19187 | Acyclovir elaidate | Inhibitor | / | Unkown |
| HY-50723S1 | 3-Methylxanthine-d3 | / | Unkown | |
| HY-B0281AS | Ranitidine-d6 hydrochloride | Antagonist | 97.00% | Unkown |
| HY-B1421S2 | Ractopamine-d3 hydrochloride | Agonist | 98.30% | Unkown |
| HY-B2058 | Triticonazole | 95.73% | Unkown | |
| HY-B2060S1 | Tiamulin-d10-1 hydrochloride | Inhibitor | / | Unkown |
| HY-N15587 | Gostatin | Inhibitor | / | Unkown |
| HY-N3136 | Onitin | Antagonist | / | Unkown |
| HY-N4031 | Humantenine | Chemical | 98% | Unkown |
| HY-N7648 | Atherosperminine | Inhibitor | / | Unkown |
| HY-N7648A | Atherosperminine hydrochloride | Inhibitor | / | Unkown |
| HY-N9554 | WIN-64821 | Antagonist | / | Unkown |
| HY-RS16281 | BRD4 Pig Pre-designed siRNA Set A | / | Unkown | |
| HY-RS16302 | PKD2 Pig Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS29448 | ILF2 Pig Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS29460 | SREBF1 Pig Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS29485 | TLR2 Pig Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W102356 | Phenethyl acetate | 99.27% | Unkown | |
| HY-W102356S1 | Phenethyl acetate-13C2 | / | Unkown | |
| HY-W102356S2 | Phenethyl acetate-d5 | / | Unkown | |
| HY-W412336 | Acid blue 129 | Antagonist | / | Unkown |
| HY-W754020 | Elbanizine | Inhibitor | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P990197 | Anti-Mouse MAdCAM-1 Antibody (MECA-367) | Inhibitor | 96.72% | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service